Cerevel Therapeutics Holdings Inc

NASDAQ:CERE   3:58:32 PM EDT
13.51
+0.13 (+0.97%)
Other Pre-Announcement

Cerevel Therapeutics Says Phase 1 Acute Anxiety Data For Darigabat Now Expected In Q4 Of 2021

Published: 05/17/2021 11:05 GMT
Cerevel Therapeutics Holdings Inc (CERE) - Cerevel Therapeutics Reports First Quarter 2021 Financial Results and Business Updates.
Cerevel Therapeutics Holdings Inc - Phase 1b Trial for Cvl-231 in Schizophrenia on Track for Data Mid-year 2021.
Cerevel Therapeutics Holdings Inc - Phase 1 Acute Anxiety Data for Darigabat Now Expected in Q4 of 2021.
Cerevel Therapeutics Holdings - Cash and Cash Equivalents As of March 31, 2021 Expected to Extend Cerevel's Cash Runway Into 2024.